Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-05

Clinical Trial Update: Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy? [NA]

View source ↗

Summary

Trial update on whether maternal supplementation with Lactobacillus reuteri and omega-3 fatty acids during pregnancy and lactation can lower the risk of allergi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri (Lactobacillus reuteri)
  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Ostergotland County Council, Sweden | Conditions: Allergy, Gastrointestinal Function | NA | Status: UNKNOWN